CFDs and spread bets are complex instruments and come with a high risk of losing money rapidly due to leverage.71% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Financial market research and analysis

Our analysts have their fingers on the pulse of the world's financial market news.

Spread betting and CFD trading are high risk and may not be suitable for everyone. You can lose all your deposits.
UK retailers mixed, pharmaceuticals down
UK retailers opened mixed, despite encouraging sales data across the sector.

Tesco (-2.61%) sales growth reached its highest quarterly level in five years; the 13-week like-for-like sales in the UK expanded 1.8% by the end of November. Christmas sales were encouraging, as they have been for Sainsbury’s (-0.42%) and Wm Morrison Supermarkets (-0.96%). The figures left investors unconvinced, either because they were not good enough to boost the share price, or the seasonality could bite into the figures over the next couple of weeks.

Marks & Spencer (+5.02%) diverged positively as its UK sales expanded 4.5% in the third quarter, while the international sales surged 18.9% on the back of the cheaper pound.

The pound (+0.07%) was one of the weakest performers against the dwindling US dollar, as the Bank of England Governor Mark Carney said that the Brexit had the potential to amplify risks to the UK’s economy. Still the FTSE extended its record to 7328.51p.

London banks demand a special Brexit deal, to secure their access to the EU business as well as to talent. The enthusiasm could rapidly fade given that PM Theresa May has already cited that the UK’s financial businesses would not benefit from special treatment.

The healthcare stocks were the biggest losers in London, on the back of Donald Trump’s nightmarish comments. Trump would like to see the US drug makers back to the country, but more importantly, he would like to start negotiating the drug prices, which could heavily weigh on pharmaceutical revenues.

GlaxoSmithKline (-0.60%), AstraZeneca (-1.02%) and Shire (-2.00%) were offered at the London open, Novartis (-1.48%) sold off in Zürich.


Trump’s speech disappointed amid lack of details

The US President-elect Donald Trump delivered his first press conference yesterday. The lack of details, especially regarding his fiscal policy plans, disappointed the financial markets, although he reiterated his commitment for business-friendly tax cuts, deregulation and ‘very large border tax’ to prevent US companies from shifting their production abroad.

Investors’ enthusiasm was also dented by Russian spy shenanigans, Trump’s anti-Chinese stance, the wall-building rhetoric and also the questionable ethics regarding the new President’s plans to maintain his ownership in his business empire despite leaving his responsibilities to his sons.

Donald Trump said he would be the ‘greatest jobs producer that God has ever created’, yet did not comment on concrete numbers, such as the 500 billion spending plan he had previously hinted at.

All in all, the Trump-magic didn’t happen this time around. The US Treasuries rose on no further details, while the US dollar softened. Still, the US equity markets traded marginally higher. The S&P500 gained 0.38%, while the Down Jones traded just shy from the 20’000 level.

The cherry on top, was comments made by Secretary of State Nominee Tillerson, who said that China couldn’t access the South China Sea Islands, reviving tensions with China.

The US equity futures traded down in Asia.

The Federal Reserve (Fed) Chair Janet Yellen is due to speak later in the day. We do not expect any insightful comments regarding the future of the US monetary policy. The US markets will likely trade on the Trump frustration.

The Dow Jones is called 52 points lower at $19902 the US open, the S&P500 is seen 6 points softer at $2269.


ECB doves could cap the euro appetite

The broad based USD depreciation helped the EURUSD higher. The pair extended gains to 1.0615 ahead of the release of the European Central Bank (ECB) meeting minutes due today. The ECB reduced the size of its Quantitative Easing (QE) programme from 80 to 60 billion euros, yet committed to continue its purchases until December 2017, and beyond if needed. The minutes will likely lean towards the ECB doves. If this is the case, we could see limited upside in the EURUSD. The key mid-term support stands at 1.0707 (major 38.2% retracement on post-Trump USD rally).

The information and comments provided herein under no circumstances are to be considered an offer or solicitation to invest and nothing herein should be construed as investment advice. The information provided is believed to be accurate at the date the information is produced. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Please note that 71% of our retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing money.

14-12-2020

GBP jumps on Brexit talks extension
The British pound has jumped in early trading this week after the UK Prime Minister and EU Commission President agreed to extend Brexit talks beyond Sunday. MARKETSThe S&P 500 fell on Friday, wrapping up a losing week, as the outlook for additional fiscal… Read more

10-12-2020

AirBnB IPO today
At its IPO price of $6 per share, Airbnb ABNB, is expected to raise at least $3.5 billion with an initial market capitalization topping $40 billion. MARKETSStocks fell on Wednesday, retreating from the record highs set earlier in the day, as tech shares strug… Read more

9-12-2020

S&P 500 closes over 3,700
MARKETSThe S&P 500 closed above 3,700 for the first time ever on Tuesday as Pfizer started to roll out its coronavirus vaccine in the U.K., lifting hope of the economy recovering in the near future. The Dow Jones gained 0.4% while the Nasdaq Composite clim… Read more

8-12-2020

Global stock market cap reaches $100 trillion for 1st time
The value of all the stocks in the world put together has reached a giant $100 trillion for the first time. MARKETSThe Dow fell 0.69% Monday, led by Intel and broad-based weakness in value stocks as rising Covid-19 restrictions offset optimism over an imminen… Read more

4-12-2020

Pfizer vaccine supply chain problems
MARKETS The S&P 500 fell slightly from record high. Major U.S stocks indices cut gains quickly in the final hour of trading after Dow Jones reported Pfizer now expects to ship half of the doses it had previously planned this year after finding raw materia… Read more

2-12-2020

Dollar Purge Continues
The US dollar dropped to fresh two-and-a-half year lows on Tuesday, with EUR/USD rising above the widely-watched 1.20 handle. MARKETSNews• Stocks in Asia-Pacific were mixed in Wednesday morning trade after major indexes on Wall Street surged to record highs o… Read more

1-12-2020

Bitcoin hits record high
The price of Bitcoin climbed 8.7% on Monday to reach a fresh record high of $19,857.03 - overtaking its previous peak made in 2017. MARKETSNews• Asia stocks rise as the Caixin/Markit manufacturing Purchasing Managers’ Index for November came in at 54.9 — its… Read more

30-11-2020

OPEC meeting starts
Today OPEC+ begin a 2-day meeting to decide whether to begin producing an extra 2 million barrels per day of oil, or delay for another 3-6 months. MARKETSNews• Asia-Pacific markets are mixed this morning while S&P 500 futures are down half a per cent. Ind… Read more